Keywords
Last Name

Kimberley Mak, MD, MPH

TitleAssistant Professor
InstitutionBoston University School of Medicine
DepartmentRadiation Oncology
Address830 Harrison Avenue (Moakley Building)
Boston MA 02118
Other Positions
InstitutionBoston Medical Center

 Research Expertise & Professional Interests
Dr. Kimberley S. Mak, is an Assistant Professor of Radiation Oncology with the Boston University School of Medicine and its affiliate Boston Medical Center. She received her MPH from Harvard School of Public Health (2015), MD from Harvard Medical School (2010) and AB from Harvard College (2005). Dr. Mak has been affiliated with numerous hospitals including Massachusetts General Hospital and Brigham and Women’s Hospital where she completed her Residency for Internal Medicine in 2011 and in 2015 her Residency for Radiation Oncology. Dr. Mak has board certification in Radiation Oncology, speaks both English and Cantonese, and has special interests in thoracic and gastrointestinal malignancies; patient-reported and disparity outcomes research; intensity-modulated and image-guided radiotherapy; CyberKnife® stereotactic radiotherapy; functional imaging in radiotherapy; and prospective clinical trial design.

 Publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Sperduto PW, Yang TJ, Beal K, Pan H, Brown PD, Bangdiwala A, Shanley R, Yeh N, Gaspar LE, Braunstein S, Sneed P, Boyle J, Kirkpatrick JP, Mak KS, Shih HA, Engelman A, Roberge D, Arvold ND, Alexander B, Awad MM, Contessa J, Chiang V, Hardie J, Ma D, Lou E, Sperduto W, Mehta MP. Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA). JAMA Oncol. 2016 Nov 17. PMID: 27892978.
    View in: PubMed
  2. Mak KS, Smith AB, Eidelman A, Clayman R, Niemierko A, Cheng JS, Matthews J, Drumm MR, Nielsen ME, Feldman AS, Lee RJ, Zietman AL, Chen RC, Shipley WU, Milowsky MI, Efstathiou JA. Quality of Life in Long-term Survivors of Muscle-Invasive Bladder Cancer. Int J Radiat Oncol Biol Phys. 2016 Dec 1; 96(5):1028-1036. PMID: 27727064.
    View in: PubMed
  3. Mak KS, van Bommel AC, Stowell C, Abrahm JL, Baker M, Baldotto CS, Baldwin DR, Borthwick D, Carbone DP, Chen AB, Fox J, Haswell T, Koczywas M, Kozower BD, Mehran RJ, Schramel FM, Senan S, Stirling RG, van Meerbeeck JP, Wouters MW, Peake MD. Defining a standard set of patient-centred outcomes for lung cancer. Eur Respir J. 2016 Sep; 48(3):852-60. PMID: 27390281.
    View in: PubMed
  4. Sperduto PW, Yang TJ, Beal K, Pan H, Brown PD, Bangdiwala A, Shanley R, Yeh N, Gaspar LE, Braunstein S, Sneed P, Boyle J, Kirkpatrick JP, Mak KS, Shih HA, Engelman A, Roberge D, Arvold ND, Alexander B, Awad MM, Contessa J, Chiang V, Hardie J, Ma D, Lou E, Sperduto W, Mehta MP. The Effect of Gene Alterations and Tyrosine Kinase Inhibition on Survival and Cause of Death in Patients With Adenocarcinoma of the Lung and Brain Metastases. Int J Radiat Oncol Biol Phys. 2016 Oct 1; 96(2):406-13. PMID: 27598807.
    View in: PubMed
  5. Kekre N, Mak KS, Stopsack KH, Binder M, Ishii K, Brånvall E, Cutler CS. Impact of HLA-Mismatch in Unrelated Donor Hematopoietic Stem Cell Transplantation: A Meta-Analysis. Am J Hematol. 2016 Jun; 91(6):551-5. PMID: 26927727.
    View in: PubMed
  6. Delhorme JB, Antoni D, Mak KS, Severac F, Freel KC, Schumacher C, Rohr S, Brigand C, Noel G. Treatment that follows guidelines closely dramatically improves overall survival of patients with anal canal and margin cancers. Crit Rev Oncol Hematol. 2016 May; 101:131-8. PMID: 26995081.
    View in: PubMed
  7. Mak KS, Phillips JG, Barysauskas CM, Lee LK, Mannarino EG, Van Benthuysen L, Raut CP, Mullen JT, Fairweather M, DeLaney TF, Baldini EH. Acute gastrointestinal toxicity and bowel bag dose-volume parameters for preoperative radiation therapy for retroperitoneal sarcoma. Pract Radiat Oncol. 2016 Sep-Oct; 6(5):360-6. PMID: 27009922.
    View in: PubMed
  8. Mak KS, Harris JR. Radiotherapy Issues After Neoadjuvant Chemotherapy. J Natl Cancer Inst Monogr. 2015 May; 2015(51):87-9. PMID: 26063895.
    View in: PubMed
  9. Mak KS, Chen YH, Catalano PJ, Punglia RS, Wong JS, Truong L, Bellon JR. Dosimetric Inhomogeneity Predicts for Long-Term Breast Pain After Breast-Conserving Therapy. Int J Radiat Oncol Biol Phys. 2015 Dec 1; 93(5):1087-95. PMID: 25084611.
    View in: PubMed
  10. Mak KS, Gainor JF, Niemierko A, Oh KS, Willers H, Choi NC, Loeffler JS, Sequist LV, Shaw AT, Shih HA. Significance of targeted therapy and genetic alterations in EGFR, ALK, or KRAS on survival in patients with non-small cell lung cancer treated with radiotherapy for brain metastases. Neuro Oncol. 2015 Feb; 17(2):296-302. PMID: 25053852.
    View in: PubMed
  11. Damato AL, Townamchai K, Albert M, Bair RJ, Cormack RA, Jang J, Kovacs A, Lee LJ, Mak KS, Mirabeau-Beale KL, Mouw KW, Phillips JG, Pretz JL, Russo AL, Lewis JH, Viswanathan AN. Dosimetric consequences of interobserver variability in delineating the organs at risk in gynecologic interstitial brachytherapy. Int J Radiat Oncol Biol Phys. 2014 Jul 1; 89(3):674-81. PMID: 24803035.
    View in: PubMed
  12. Mak KS, Lee LK, Mak RH, Wang S, Pile-Spellman J, Abrahm JL, Prigerson HG, Balboni TA. Incidence and treatment patterns in hospitalizations for malignant spinal cord compression in the United States, 1998-2006. Int J Radiat Oncol Biol Phys. 2011 Jul 1; 80(3):824-31. PMID: 20630663.
    View in: PubMed
  13. Kollmeier MA, Katz MS, Mak K, Yamada Y, Feder DJ, Zhang Z, Jia X, Shi W, Zelefsky MJ. Improved biochemical outcomes with statin use in patients with high-risk localized prostate cancer treated with radiotherapy. Int J Radiat Oncol Biol Phys. 2011 Mar 1; 79(3):713-8. PMID: 20452139.
    View in: PubMed
  14. Yang DP, Zhang DP, Mak KS, Bonder DE, Pomeroy SL, Kim HA. Schwann cell proliferation during Wallerian degeneration is not necessary for regeneration and remyelination of the peripheral nerves: axon-dependent removal of newly generated Schwann cells by apoptosis. Mol Cell Neurosci. 2008 May; 38(1):80-8. PMID: 18374600.
    View in: PubMed
  15. Guertin AD, Zhang DP, Mak KS, Alberta JA, Kim HA. Microanatomy of axon/glial signaling during Wallerian degeneration. J Neurosci. 2005 Mar 30; 25(13):3478-87. PMID: 15800203.
    View in: PubMed
Kimberley's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Similar BU People
_
Same Department